A phase I/Ib dose-escalation study of intravenously administered SB 11285 alone and in combination with nivolumab in patients with advanced solid tumours

被引：4
|
作者：
Luke, J. J. [1 ]
Janku, F. [2 ]
Strauss, J. [3 ]
Olszanski, A. J. [4 ]
Leach, K. [5 ]
Radhakrishnan, I. [5 ]
Abbas, A. [5 ]
机构：
[1] UPMC Hillman Canc Ctr, Med, Pittsburgh, PA USA
[2] Univ Texas MD Anderson Canc Ctr, Invest Canc Therapeut, Houston, TX 77030 USA
[3] Mary Crowley Med Res Ctr, Oncol, Dallas, TX USA
[4] Fox Chase Canc Ctr, Med Oncol, Main Campus, Philadelphia, PA 19111 USA
[5] Spring Bank Pharmaceut, Oncol Dept, Hopkinton, MA USA
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.712
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
598TiP
引用
收藏
页码：S500 / S500
页数：1
相关论文
共 50 条
  • [1] A phase Ia/Ib dose-escalation study of intravenously administered SB 11285 alone and in combination with nivolumab in patients with advanced solid tumors.
    Janku, Filip
    Strauss, James
    Karim, Raghad
    Olszanski, Anthony J.
    Luke, Jason J.
    Leach, Kevin
    Iyer, Radhakrishnan
    Abbas, Atif
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] A PHASE 1A/1B DOSE-ESCALATION STUDY OF INTRAVENOUSLY ADMINISTERED SB 11285 ALONE AND IN COMBINATION WITH NIVOLUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS
    Abbas, A.
    Strauss, J.
    Janku, F.
    Karim, R.
    Olszanski, A.
    Luke, J. J.
    Leach, K.
    Iyer, R.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A7 - A8
  • [3] A PHASE 1/1B DOSE-ESCALATION STUDY OF INTRAVENOUSLY ADMINISTERED SB 11285 ALONE AND IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH ADVANCED SOLID TUMORS
    Luke, Jason
    Janku, Filip
    Olszanski, Anthony
    Leach, Kevin
    Iyer, Radhakrishnan
    Abbas, Atif
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A224 - A224
  • [4] A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours
    Diaz-Padilla, I.
    Siu, L. L.
    San Pedro-Salcedo, M.
    Razak, A. R. A.
    Colevas, A. D.
    Shepherd, F. A.
    Leighl, N. B.
    Neal, J. W.
    Thibault, A.
    Liu, L.
    Lisano, J.
    Gao, B.
    Lawson, E. B.
    Wakelee, H. A.
    BRITISH JOURNAL OF CANCER, 2012, 107 (04) : 604 - 611
  • [5] A phase I dose-escalation study of aflibercept administered in combination with pemetrexed and cisplatin in patients with advanced solid tumours
    I Diaz-Padilla
    L L Siu
    M San Pedro-Salcedo
    A R A Razak
    A D Colevas
    F A Shepherd
    N B Leighl
    J W Neal
    A Thibault
    L Liu
    J Lisano
    B Gao
    E B Lawson
    H A Wakelee
    British Journal of Cancer, 2012, 107 : 604 - 611
  • [6] Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours
    Takashi Seto
    Taito Esaki
    Fumihiko Hirai
    Shuji Arita
    Kaname Nosaki
    Akitaka Makiyama
    Takuro Kometani
    Chinatsu Fujimoto
    Motoharu Hamatake
    Hiroaki Takeoka
    Felix Agbo
    Xiaojin Shi
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 619 - 627
  • [7] Phase I, dose-escalation study of AZD7762 alone and in combination with gemcitabine in Japanese patients with advanced solid tumours
    Seto, Takashi
    Esaki, Taito
    Hirai, Fumihiko
    Arita, Shuji
    Nosaki, Kaname
    Makiyama, Akitaka
    Kometani, Takuro
    Fujimoto, Chinatsu
    Hamatake, Motoharu
    Takeoka, Hiroaki
    Agbo, Felix
    Shi, Xiaojin
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (03) : 619 - 627
  • [8] Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors
    A. Craig Lockhart
    Shankar Sundaram
    John Sarantopoulos
    Monica M. Mita
    Andrea Wang-Gillam
    Jennifer L. Moseley
    Stephanie L. Barber
    Alex R. Lane
    Claudine Wack
    Laurent Kassalow
    Jean-François Dedieu
    Alain C. Mita
    Investigational New Drugs, 2014, 32 : 1236 - 1245
  • [9] Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors
    Lockhart, A. Craig
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Wang-Gillam, Andrea
    Moseley, Jennifer L.
    Barber, Stephanie L.
    Lane, Alex R.
    Wack, Claudine
    Kassalow, Laurent
    Dedieu, Jean-Francois
    Mita, Alain C.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (06) : 1236 - 1245
  • [10] Phase I dose-escalation study of aflibercept in combination with docetaxel and cisplatin in patients with advanced solid tumours
    Freyer, G.
    Isambert, N.
    You, B.
    Zanetta, S.
    Falandry, C.
    Favier, L.
    Trillet-Lenoir, V.
    Assadourian, S.
    Soussan-Lazard, K.
    Ziti-Ljajic, S.
    Fumoleau, P.
    BRITISH JOURNAL OF CANCER, 2012, 107 (04) : 598 - 603
12345